Abstract
Genetic predictors of beta-lactam (BL) allergy are mostly related to Immunoglobulin E (IgE) synthesis and atopy. Despite this context, little attention has been devoted to genes of IgE/FcɛRI pathway, such as galectin-3, a β-galactoside-binding lectin, which binds to IgE. We evaluated the association of LGALS3 polymorphisms with BL allergy in 395 Spanish and 198 Italian cases, compared with 310- and 339-matched controls, respectively. The rs11125 predicted BL allergy with an odds ratio of 4.0 in Spanish population (P<0.0001). This association was replicated with an odds ratio of 5.1 in Italian population (P<0.0001); rs11125 predicted also increased serum level of total IgE in Spanish controls. These data are consistent with the predicted deleterious influence of Gln>His substitution produced by rs11125 on galactose-binding activity of galectin-3. In conclusion, LGALS3 is the strongest genetic predictor of BL allergy reported so far. This association reflects the influence of genes of IgE/FcɛRI pathway in this pathology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Gomes ER, Demoly P . Epidemiology of hypersensitivity drug reactions. Curr Opin Allergy Clin Immunol 2005; 5: 309–316.
Gueant JL, Gueant-Rodriguez RM, Viola M, Valluzzi RL, Romano A . IgE-mediated hypersensitivity to cephalosporins. Curr Pharm Des 2006; 12: 3335–3345.
Gueant JL, Gueant-Rodriguez RM, Gastin IA, Cornejo-Garcia JA, Viola M, Barbaud A et al. Pharmacogenetic determinants of immediate and delayed reactions of drug hypersensitivity. Curr Pharm Des 2008; 14: 2770–2777.
Cornejo-Garcia JA, Gueant-Rodriguez RM, Torres MJ, Blanca-Lopez N, Tramoy D, Romano A et al. Biological and genetic determinants of atopy are predictors of immediate-type allergy to betalactams, in Spain. Allergy 2012; 67: 1181–1185.
Qiao HL, Yang J, Zhang YW . Relationships between specific serum IgE, cytokines and polymorphisms in the IL-4, IL-4Ralpha in patients with penicillins allergy. Allergy 2005; 60: 1053–1059.
Gueant-Rodriguez RM, Romano A, Beri-Dexheimer M, Viola M, Gaeta F, Gueant JL . Gene-gene interactions of IL13 and IL4RA variants in immediate allergic reactions to betalactam antibiotics. Pharmacogenet Genomics 2006; 16: 713–719.
Guglielmi L, Fontaine C, Gougat C, Avinens O, Eliaou JF, Guglielmi P et al. IL-10 promoter and IL4-Ralpha gene SNPs are associated with immediate beta-lactam allergy in atopic women. Allergy 2006; 61: 921–927.
Qiao HL, Yang J, Zhang YW . Specific serum IgE levels and FcepsilonRIbeta genetic polymorphism in patients with penicillins allergy. Allergy 2004; 59: 1326–1332.
Gueant JL, Romano A, Cornejo-Garcia JA, Oussalah A, Chery C, Viola M et al. HLA-DRA variants predict penicillin allergy in genomewide fine-mapping genotyping. J Allergy Clin Immunol 2014; 135: 253–259.
Gould HJ, Sutton BJ . IgE in allergy and asthma today. Nat Rev Immunol 2008; 8: 205–217.
Chen HY, Sharma BB, Yu L, Zuberi R, Weng IC, Kawakami Y et al. Role of galectin-3 in mast cell functions: galectin-3-deficient mast cells exhibit impaired mediator release and defective JNK expression. J Immunol 2006; 177: 4991–4997.
Saegusa J, Hsu DK, Chen HY, Yu L, Fermin A, Fung MA et al. Galectin-3 is critical for the development of the allergic inflammatory response in a mouse model of atopic dermatitis. Am J Pathol 2009; 174: 922–931.
Bursztejn AC, Romano A, Guéant-Rodriguez RM, Cornejo JA, Oussalah A, Chery C et al. Allergy to betalactams and nucleotide-binding oligomerization domain (NOD) gene polymorphisms. Allergy 2013; 68: 1076–1080.
Torres MJ, Blanca M, Fernandez J, Romano A, Weck A, Aberer W et al. Diagnosis of immediate allergic reactions to beta-lactam antibiotics. Allergy 2003; 58: 961–972.
deBoer RA, Verweij N, van Veldhuisen DJ, Westra HJ, Bakker SJ, Gansevoort RT et al. A genome-wide association study of circulating galectin-3. PLoS One 2012; 7: e47385.
Nam YH, Kim JE, Kim SH, Jin HJ, Hwang EK, Shin YS et al. Identifying genetic susceptibility to sensitization to cephalosporins in health care workers. J Korean Med Sci 2012; 27: 1292–1299.
Cornejo-Garcia JA, Fernandez TD, Torres MJ, Carballo M, Hernan I, Antunez C et al. Differential cytokine and transcription factor expression in patients with allergic reactions to drugs. Allergy 2007; 62: 1429–1438.
Platzer B, Ruiter F, van der Mee J, Fiebiger E . Soluble IgE receptors—elements of the IgE network. Immunol Lett 2011 30; 141: 36–44.
Acknowledgements
Dr Cornejo-García is a postdoctoral researcher and Pr Miguel Blanca is visiting full professor at the Medical Faculty, University of Nancy. Manuscript was supported in part by Grants from Inserm, the Lorraine Region and PHRC (Hospital clinical research program, 2012, PHRC 189), and from Spanish Ministry Fund for Health in Spain (FIS) network RIRAAF (RD12/0013), and PS09/02419.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Cornejo-García, J., Romano, A., Guéant-Rodríguez, R. et al. A non-synonymous polymorphism in galectin-3 lectin domain is associated with allergic reactions to beta-lactam antibiotics. Pharmacogenomics J 16, 79–82 (2016). https://doi.org/10.1038/tpj.2015.24
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2015.24
This article is cited by
-
Genetic Variants Associated With Drug-Induced Hypersensitivity Reactions: towards Precision Medicine?
Current Treatment Options in Allergy (2021)
-
How Mechanism Knowledge Can Help to Management of Drug Hypersensitivity
Current Treatment Options in Allergy (2020)
-
Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions
Current Treatment Options in Allergy (2019)
-
Epidemiology and Risk Factors in Drug Hypersensitivity Reactions
Current Treatment Options in Allergy (2017)